TrialPath
Recruiting

Probiotics in Pulmonaty Rehabilitation for COPD

NCT06717659 · Fu Jen Catholic University
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Probiotics in the Management of Pulmonary Rehabilitation for COPD: A Randomized Controlled Trial
About this study
Background: Patients with chronic obstructive pulmonary disease (COPD) often suffer from malnutrition and weight loss, which negatively impact mortality rates. Research indicates that insufficient intake of fiber, vitamins, and folic acid is associated with airflow limitation in COPD. Malnutrition affects lung function and muscle strength, leading to difficulty in breathing and reduced exercise tolerance. Nutritional support interventions, such as probiotics, are valuable in improving the nutritional status, lung function, and pulmonary rehabilitation in COPD patients. Study Design: This is a one-year, single-center, prospective randomized controlled trial. Methods: This study is a randomized controlled trial targeting COPD patients undergoing pulmonary rehabilitation. The plan is to recruit 60 participants, randomly assigned to either the probiotic intervention group or the conventional pulmonary rehabilitation group. The study includes physiological parameters, functional tests, questionnaires, and blood biochemical analyses. Data will be analyzed using SPSS, with statistical significance set at p \< 0.05. Effect: The trial expects that COPD patients receiving probiotic supplementation will achieve significant muscle gain and fat loss, reduce inflammation, and exhibit changes in body composition and functional performance. Key words: Chronic obstructive pulmonary disease; probiotics; nutritional supplementation; inflammation markers; body composition
Eligibility criteria
Inclusion Criteria: * Willing to sign a written informed consent form. * Diagnosed with pre-COPD or COPD stage I-IV according to the 2023 GOLD guidelines. * Undergoing pulmonary rehabilitation therapy for more than three months. Exclusion Criteria: * Under 18 years old. * Diagnosed with neuromuscular diseases. * Experienced respiratory disease exacerbation requiring emergency care or hospitalization in the past three months. * Unable to cooperate with cardiopulmonary exercise testing. * Has other diseases or behavioral restrictions preventing participation in exercise training for over one year. * Assessed by a physician to have severe malnutrition or a significantly low BMI.
Study design
Enrollment target: 60 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2024-12-05
Estimated completion: 2026-12-31
Last updated: 2026-02-27
Interventions
Other: probiotic supplementation interventionOther: standard pulmonnary rehabilitation
Primary outcomes
  • • interleukin-6 (six weeks)
Sponsor
Fu Jen Catholic University · other
Contacts & investigators
ContactKe-Yun Chao, PhD · contact · C00152@mail.fjuh.fju.edu.tw · +886-905-301-879
InvestigatorKe-Yun Chao, PhD · principal_investigator, Fu Jen Catholic University
All locations (1)
Fu Jen Catholic University Hospital, Fu Jen Catholic UniversityRecruiting
New Taipei City, Taiwan
Probiotics in Pulmonaty Rehabilitation for COPD · TrialPath